Related references
Note: Only part of the references are listed.Management of mitochondrial diabetes in the era of novel therapies
Roseanne O. Yeung et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2021)
MELAS Syndrome and MIDD Unmasked by Metformin Use: A Case Report
Na Hyun Kim et al.
ANNALS OF INTERNAL MEDICINE (2021)
Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness - Evaluation of Predicting Parameters
Philipp L. Muller et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)
Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia
Mariana Igoillo-Esteve et al.
JCI INSIGHT (2020)
Resolving complexity in mitochondrial disease: Towards precision medicine
Roisin M. Boggan et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
Qingmiao Shao et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease
Rachel L. Boal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
Taichi Nagahisa et al.
DIABETES THERAPY (2019)
mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
John P. Grady et al.
EMBO MOLECULAR MEDICINE (2018)
Recent Advances in Detecting Mitochondrial DNA Heteroplasmic Variations
Mengqin Duan et al.
MOLECULES (2018)
Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes
Roseanne O. Yeung et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2018)
Mitochondrial donation: from test tube to clinic
Grainne S. Gorman et al.
LANCET (2018)
A retrospective analysis of health care utilization for patients with mitochondrial disease in the United States: 2008-2015
Bruce Cohen et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences
Eric Fontaine
FRONTIERS IN ENDOCRINOLOGY (2018)
Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
Sumit Parikh et al.
GENETICS IN MEDICINE (2017)
Mitochondrial diseases
Grainne S. Gorman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?
Michelangelo Mancuso et al.
JOURNAL OF NEUROLOGY (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Adverse drug reaction and causality assessment scales
Syed Ahmed Zaki
LUNG INDIA (2011)
Drugs interfering with mitochondrial disorders
Josef Finsterer et al.
DRUG AND CHEMICAL TOXICOLOGY (2010)
Mitochondrial metabolism and diabetes
Soo Heon Kwak et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A > G mitochondrial point mutation
R. Murphy et al.
DIABETIC MEDICINE (2008)
The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2
Florin Sasarman et al.
HUMAN MOLECULAR GENETICS (2008)
Wolff-Parkinson-White syndrome in patients with MELAS
Douglas M. Sproule et al.
ARCHIVES OF NEUROLOGY (2007)
Prevalence and progression of diabetes in mitochondrial disease
R. G. Whittaker et al.
DIABETOLOGIA (2007)
Coenzyme Q10 and statins:: Biochemical and clinical implications
Gian Paolo Littarru et al.
MITOCHONDRION (2007)
Population prevalence of the MELAS A3243G mutation
Neil Manwaring et al.
MITOCHONDRION (2007)
Molecular mechanisms of mitochondrial diabetes (MIDD)
JA Maassen et al.
ANNALS OF MEDICINE (2005)
Maternally inherited diabetes and deafness: A multicenter study
PJ Guillausseau et al.
ANNALS OF INTERNAL MEDICINE (2001)
Hearing impairment in patients with 3243A→G mtDNA mutation:: phenotype and rate of progression
S Uimonen et al.
HUMAN GENETICS (2001)
Mitochondrial DNA A3243G mutation in patients with early- or late-onset type 2 diabetes mellitus in Hong Kong Chinese
MCY Ng et al.
CLINICAL ENDOCRINOLOGY (2000)
Share Paper
